Machine Learning

A new partnership uses AI to analyze imaging, clinical, and molecular data, offering unprecedented accuracy in predicting breast cancer recurrence years later.

Serve Robotics and Uber Eats launch sidewalk robots in Alexandria, Va., testing the scalability, economics, and public acceptance of last-mile automation.

Serina Therapeutics has answered the FDA's challenge. A 30-day clock now ticks on its novel Parkinson's therapy and its disruptive drug delivery platform.

Early trial data suggests GRI-0621 could be a game-changer for Idiopathic Pulmonary Fibrosis, showing lung repair and a much better safety profile.

BridgeBio Oncology's new drug candidate BBO-10203 could redefine cancer therapy by avoiding a key toxicity, unlocking a vast market.

Aardvark Therapeutics' pivotal trial for Prader-Willi syndrome goes global, a key step toward commercializing its novel hunger-suppressing drug.

A small biotech is challenging oncology's giants with a drug that targets cancer's core weakness, offering new hope to the sickest lung cancer patients.

Canada adds four groups to its terror list, taking a bold stand against online networks preying on youth and global insurgencies. Here's what it means.

Vision Fortune Finance Institute unveils a powerful new data engine for its Nexus AI, aiming to revolutionize financial research by taming data overload.

Beyond the headline, Azul's acquisition of Payara signals a major shift, creating a unified open-source alternative to challenge proprietary Java platforms.

A new NTC thermistor, smaller than a grain of rice, offers the precision and durability needed to power the next wave of EVs, ADAS, and smart devices.

WelcomeVille Investment Association is launching a platform to fix 'cognitive drift'. Is this the future of professional development or a niche experiment?

WeVisu's AI platform is bringing stability to the chaotic home remodeling market, reducing costs and empowering contractors with unprecedented digital tools.

A $2.4B deal for AI's future. A hedge fund's strategic play. We decode the battle for Alphawave, the company powering the next tech revolution.

A hedge fund's 2.34% derivatives stake in Alphawave IP suggests a major acquisition by Qualcomm, highlighting a high-stakes battle for key chip IP.

A V2G pioneer pivots its intelligent software to compete for a massive national energy storage contract in South Korea's booming, high-stakes market.

ThoughtSpot's new suite of BI agents signals a major shift from static reports to autonomous action. But can it overcome the hurdles of trust and adoption?

Advanced AI is reshaping how destinations target travelers. These data-driven strategies offer a powerful playbook for healthcare's patient engagement challenges.

A new partnership seeks to unify viewership, channel, and ad data across all 210 US markets, promising unprecedented precision for local advertisers.

A struggling interactive entertainment firm bets its future on gold, targeting Malaysia's booming market. A look at the high-stakes pivot shaking up BHAT.